Tracking CYTK? Get live short interest, options flow, and signals on ORTEX.Sign up free →

Cytokinetics, Incorporated (CYTK) short interest & options flow

NASDAQ

Cytokinetics goes into Thursday's earnings release with short sellers holding a meaningful position, yet the lending market tells a more relaxed story than the headline short interest implies. Short interest has climbed 6.6% over the past month to reach 15.2% of the free float, roughly 18.6 million shares. That is a genuinely elevated level for a mid-cap biotech, and it places the…

$63.60+2.07% 1d+3.79% 1w-3.05% 1mClose: 4 Nov 2026

Short interest % of float: High; Live SI on ORTEX →
Cost to borrow: Low; Live CTB on ORTEX →

Market cap: $8.92B
Next earnings: 6 Nov 2026

See the full picture on ORTEX →Live short interest, options flow, signals, 13F filings, and more.

Key data as of 5 Nov 2026

ORTEX chart of Cytokinetics, Incorporated (CYTK) share price and short interest (% of free float), six months to November 4, 2026

CYTK news and analysis

RSS

No long-form analysis yet for CYTK. Pulse alerts and the live data picture are available on ORTEX.

Open CYTK on ORTEX →

Want the live picture for CYTK?

Short interest updated daily, real-time options flow, analyst consensus deltas, 13F positioning, ORTEX Alpha signals, and every article ORTEX publishes for CYTK — free to start on ORTEX.

We value your privacy

CYTK news and analysis

Want the live picture for CYTK?